Drugs · acquisition-cost intelligence
DECONEX DMX
Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride· ingredient dextromethorphanAdrenergic and dopaminergic agents· DEXTROMETHORPHAN HYDROBROMIDE 17.5 mg/1; GUAIFENESIN 400 mg/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$0.67170
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per EA — the trend nobody else shows. 4 weeks.
2025-12-172026-03-18
Same-ingredient options by acquisition cost
Other dextromethorphan products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.
| Product | NADAC / EA | vs this |
|---|---|---|
| ACTINEL Diabetic | $0.01104 | −$0.66070 |
| adult cough and chest congestion | $0.01973 | −$0.65200 |
| BACTIMICINA COUGH AND COLD | $0.02085 | −$0.65080 |
| 7 Select Maximum Strength | $0.02142 | −$0.65030 |
| Adult Cough Relief | $0.02292 | −$0.64880 |
| Promethazine DM | $0.03852 | −$0.63320 |
| AMAZON Childrens Multi Symptom Cold | $0.04678 | −$0.62490 |
| 12 HR RELIEF COUGH DM | $0.06804 | −$0.60370 |
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.